Скачать с ютуб Vaccine Induced Immune Thrombotic Thrombocytopenia: Reflections and Future Directions в хорошем качестве

Vaccine Induced Immune Thrombotic Thrombocytopenia: Reflections and Future Directions

Vaccine induced immune thrombotic thrombocytopenia (VITT) is a rare but serious complication that has been associated with adenoviral vector vaccines to the Sars-CoV-2 virus. This presentation will review what is known (and unknown) about VITT, discussing its discovery in March 2021, landmark studies that explored its pathophysiology, its epidemiology in Canada around the globe, and its management. Cases of VITT in Canada have fallen as uptake of the AstraZeneca COVID-19 vaccine has fallen, however this rare vaccine associated adverse reaction informs our understanding of how to manage other unusual and severe blood clots. This presentation is by Dr Menaka Pai, Hamilton from the 2021 Thrombosis Canada annual conference.